Blood component therapy and transfucion reactions
-
Upload
mercury-lin -
Category
Health & Medicine
-
view
590 -
download
1
Transcript of Blood component therapy and transfucion reactions
![Page 1: Blood component therapy and transfucion reactions](https://reader031.fdocuments.net/reader031/viewer/2022021922/58738f8b1a28ab272d8b79cf/html5/thumbnails/1.jpg)
BLOOD COMPONENT THERAPY
AND TRANSFUSION REACTIONS
Mercury Y. Lin, MD FCAP
LCDR MC USN
Staff Pathologist
16FEB2011
15JAN2014
![Page 2: Blood component therapy and transfucion reactions](https://reader031.fdocuments.net/reader031/viewer/2022021922/58738f8b1a28ab272d8b79cf/html5/thumbnails/2.jpg)
Acknowledgement/References:
• D. Joe Chaffin, MD, “Blood Bank I-VII,” Osler Institute
• CDR Fahie, MSC, USN, “Blood Component Therapy”
• CDR Cox, MC, USN, “Blood Bank on-call”
• Marian Petrides, MD, “Practical Guide to Transfusion
Medicine.”
• AABB, “Standards for Blood Bank and Transfusion
Service, 26th Ed.”
• AABB, “Technical Manual, 15th Ed.”
• Naval Hospital Laboratory SOPs (depending on site of
lecture)
![Page 3: Blood component therapy and transfucion reactions](https://reader031.fdocuments.net/reader031/viewer/2022021922/58738f8b1a28ab272d8b79cf/html5/thumbnails/3.jpg)
Disclosure Statement
• I have no financial interest with manufacturers or any
commercial products.
• Unlabeled / unapproved use of drugs or devices will not
be discussed during this presentation.
• Medicine is an evolving professional art that tries its best
to keep up with scientific discoveries. Always consult
updated medical references in your patient care.
![Page 4: Blood component therapy and transfucion reactions](https://reader031.fdocuments.net/reader031/viewer/2022021922/58738f8b1a28ab272d8b79cf/html5/thumbnails/4.jpg)
Objectives
• 1. Describe common blood products (components) and
discuss indication for their usage.
• 2. Brief overview of transfusion reactions and other
complications of blood transfusion.
![Page 5: Blood component therapy and transfucion reactions](https://reader031.fdocuments.net/reader031/viewer/2022021922/58738f8b1a28ab272d8b79cf/html5/thumbnails/5.jpg)
![Page 6: Blood component therapy and transfucion reactions](https://reader031.fdocuments.net/reader031/viewer/2022021922/58738f8b1a28ab272d8b79cf/html5/thumbnails/6.jpg)
Blood Components
Covered in this presentation:
• Whole Blood
• Packed Red Blood Cells (PRBC)
• Platelets (Plt)
• Fresh Frozen Plasma (FFP)
• Cryoprecipitate (Cryo)
Not discussed:
• Granulocyte infusion
• Plasma derivatives
• Blood substitutes
(Hb based O2 carrier: Biopure, PolyHeme)
(Perfluorocarbon: Oxygent)
![Page 7: Blood component therapy and transfucion reactions](https://reader031.fdocuments.net/reader031/viewer/2022021922/58738f8b1a28ab272d8b79cf/html5/thumbnails/7.jpg)
Whole Blood
Soft spin (2000 RPM x 3 min)
pRBC Platelet Rich Plasma
Hard spin (5000 RPM x 5 min)
Platelet (conc.) Fresh Frozen
Plasma
Cryo ppt. Plasma
derivatives
Apheresis
donor
screening
![Page 8: Blood component therapy and transfucion reactions](https://reader031.fdocuments.net/reader031/viewer/2022021922/58738f8b1a28ab272d8b79cf/html5/thumbnails/8.jpg)
Whole Blood
• The “original blood product.”
• Not used in most healthcare facilities.
• Applications in operational setting, trauma, massive transfusion.
• Specs: 450-500 ml
• 200 ml pRBC
• 250 ml plasma
• WBCs
• Platelets
• Anticoagulants (70 ml).
• Whole blood transfusion needs to be ABO identical
![Page 9: Blood component therapy and transfucion reactions](https://reader031.fdocuments.net/reader031/viewer/2022021922/58738f8b1a28ab272d8b79cf/html5/thumbnails/9.jpg)
Packed Red Blood Cells (PRBC)
• Spec: 250 ml (350ml w/ additives)
• Each unit of PRBC has 200-250mg of iron.
• Increase Hct by 3% and Hgb by 1g/dL
• In a pediatric patient, RBC transfusion of 8-10mL/kg will
raise will raise the hemoglobin level about 2 g/dL or the
HCT by about 6%.
• Depending on where you are stationed, it maybe available
different varieties.
![Page 10: Blood component therapy and transfucion reactions](https://reader031.fdocuments.net/reader031/viewer/2022021922/58738f8b1a28ab272d8b79cf/html5/thumbnails/10.jpg)
Packed Red Blood Cells (PRBC)
• Leukocyte Reduced PRBC:
• Contains less than 5 x 106 leukocytes per unit [3 log
reduction (99.9%) (AABB standard)]
• The standard 170 micron filter does not remove leukocytes
• Best achieved after collection (prestorage)
• Prestorage leukoreduction results lower levels of cytokine
generation in the blood bag during storage and decreases risk
of febrile nonhemolytic transfusion reactions (FNHTR)
• Reduce HLA alloimmunization. Patients who receive frequent
transfusions and women who have had multiple pregnancies
may become alloimmunized to leukocyte antigens
• Reduce platelet refractoriness
![Page 11: Blood component therapy and transfucion reactions](https://reader031.fdocuments.net/reader031/viewer/2022021922/58738f8b1a28ab272d8b79cf/html5/thumbnails/11.jpg)
Packed Red Blood Cells (PRBC)
• Leukocyte Reduced PRBC (con’t):
• Immunosuppressed, cytomegalovirus (CMV) sero-negative patients such as allogeneic stem cell hematopoietic or progenitor cell recipients who are susceptible to transfusion transmitted CMV
• Also reduces risk of other obligate intracellular virus (HTLV, EBV).
• Controversial: reduce risk of prion disease? (as practiced in UK and Canada).
• Reduce transfusion related immunomodulation (TRIM)– changes in the host immune function or immunosuppression
• Reduce risk of bacterial contamination?
• DOES NOT prevent transfusion associated graft versus host disease (TA-GVHDz).
![Page 12: Blood component therapy and transfucion reactions](https://reader031.fdocuments.net/reader031/viewer/2022021922/58738f8b1a28ab272d8b79cf/html5/thumbnails/12.jpg)
Packed Red Blood Cells (PRBC)
• Leukocyte Reduced PRBC (con’t):
• Disadvantages:
• $$$
• Anaphylactoid reaction: with bedside leukoreduction, pts
taking ACE inhibitor Tx can develop severe hypotension
[due to ACE inhibitors blocking breakdown of bradykinin,
which are induced with interaction with filter surfaces].
![Page 13: Blood component therapy and transfucion reactions](https://reader031.fdocuments.net/reader031/viewer/2022021922/58738f8b1a28ab272d8b79cf/html5/thumbnails/13.jpg)
Packed Red Blood Cells (PRBC)
• Irradiated pRBC:
• Serves to deactivate lymphocytes and prevent TA-GVHDz in at risk population.
• TA-GVHDz is rare but uniformly fatal!!!
At risk population for TA-GVHDz:
- Recipient of stem cell transplant
- Hematologic malignancies
- Selected solid tumors (neuroblastoma, rhabdomyosarcoma, glioblastoma).
- Intrauterine transfusion
- Premature infants
- Pts on purine analog chemoTx
- HLA match blood product
- Direct donor blood (from blood relatives).
![Page 14: Blood component therapy and transfucion reactions](https://reader031.fdocuments.net/reader031/viewer/2022021922/58738f8b1a28ab272d8b79cf/html5/thumbnails/14.jpg)
Donor lymphocyte Host (recipient) lymphocyte
Source: Chaffin, Blood Bank III, Osler Inst.
![Page 15: Blood component therapy and transfucion reactions](https://reader031.fdocuments.net/reader031/viewer/2022021922/58738f8b1a28ab272d8b79cf/html5/thumbnails/15.jpg)
Related Donor or HLA-matched blood products.
Source: Chaffin, Blood Bank III, Osler Inst.
![Page 16: Blood component therapy and transfucion reactions](https://reader031.fdocuments.net/reader031/viewer/2022021922/58738f8b1a28ab272d8b79cf/html5/thumbnails/16.jpg)
Packed Red Blood Cells (PRBC)
• Washed pRBC:
• Red cells washed with 1 or 2L of normal saline to
removes all but traces of plasma, removes platelets, and
cellular debris.
• Indications:
• - pt with IgA deficiency (who makes anti-IgA Abs, so wash
pRBC to prevent anaphylaxis).
• Deglycs frozen pRBS is mostly equivalent to washed
pRBC
![Page 17: Blood component therapy and transfucion reactions](https://reader031.fdocuments.net/reader031/viewer/2022021922/58738f8b1a28ab272d8b79cf/html5/thumbnails/17.jpg)
Packed Red Blood Cells (PRBC)
• Indications for pRBC:
• Increase oxygen carrying capacity
• Hgb < 7g/dL or HCT < 21% in a healthy person
• 7-9g/dL in symptomatic patients with cardiopulmonary or cerebrovascular risk
• Great for patients at risk for circulatory overload (neonates and CHF)
• Exchange transfusion for HDN or acute chest syndrome in sickle cell disease
• Hgb S <30% for stroke prevention in sickle cell disease.
• Not indicated for pRBC:
• Loss of <20% blood volume (crystalloids should be adequate in most cases, but may get pRBC)
• Chronic and nutritional anemia
• Competing in Tour de France
![Page 18: Blood component therapy and transfucion reactions](https://reader031.fdocuments.net/reader031/viewer/2022021922/58738f8b1a28ab272d8b79cf/html5/thumbnails/18.jpg)
Packed Red Blood Cells (PRBC)
• If there is no other way around it and you must
concurrently infuse pRBC with another solution. Only
these fluids are compatible with pRBC
• 1) Normal saline (0.9%)
• 2) ABO compatible plasma
• 3) 5% albumin.
• NEVER give pRBC with D5W, 1/2NS, TPN, Antibiotics,
Lactate Ringer’s.
![Page 19: Blood component therapy and transfucion reactions](https://reader031.fdocuments.net/reader031/viewer/2022021922/58738f8b1a28ab272d8b79cf/html5/thumbnails/19.jpg)
![Page 20: Blood component therapy and transfucion reactions](https://reader031.fdocuments.net/reader031/viewer/2022021922/58738f8b1a28ab272d8b79cf/html5/thumbnails/20.jpg)
Platelets (Plt)
• Platelet Concentrates (Prepared from the plasma of whole
blood, not commonly used nowadays, “1 of 6 pack”)
• Apheresis Platelets (aka SDP: “single donor platelet”):
Collected from an individual donor during a 1-2 hour
apheresis procedure. 1 SDP = 6 plt concentrate.
• Spec of SDP: 100 ml
• > 3 x 1011 plts (in 90% tested units)
• minor amounts of plasma, WBC.
• Advantages of SDP: 1 donor vs. 6 donor exposure
• decrease risk of contamination.
![Page 21: Blood component therapy and transfucion reactions](https://reader031.fdocuments.net/reader031/viewer/2022021922/58738f8b1a28ab272d8b79cf/html5/thumbnails/21.jpg)
Platelets (plt)
• Dosing of plt:
• 1 unit of platelet per 10kg body weight or 4 to 8 units for a 70kg adult
• A repeat failure to achieve hemostasis or achieve the expected increment count may signify refractoriness
• Refractoriness may be associated with bleeding, amphotericin, splenomegaly, DIC, fever, sepsis, or stem cell transplantation
• Refractoriness is suspected when there is a poor post-transfusion platelet count increment.
• 1 SDP expect 30,000 ~ 60,000 plt bump
![Page 22: Blood component therapy and transfucion reactions](https://reader031.fdocuments.net/reader031/viewer/2022021922/58738f8b1a28ab272d8b79cf/html5/thumbnails/22.jpg)
Platelets (plt)
Corrected count increment (CCI):
CCI = (Post Tx plt ct) – (Pre Tx plt ct) x BSA
# Platelets transfused [in x 1011 ]
Pre-tx plt ct = pretransfusion platelet count
Post-tx plt ct = posttransfusion platelet count (10min – 1 hr
s/p transfusion)
BSA = Body surface area in m2
Each unit of concentrate: 6 x 1010 platelets
SPD platelets: 3 x 1011 platelets
• CCI of > 5000 is considered adequate response.
![Page 23: Blood component therapy and transfucion reactions](https://reader031.fdocuments.net/reader031/viewer/2022021922/58738f8b1a28ab272d8b79cf/html5/thumbnails/23.jpg)
Platelets (plt)
• Corrected count increment (CCI):
• pt (BSA of 1.7 m2 ) received 1 SDP and plt count increased from 10,000/ul to 30,000/ul (1hr post)
• CCI = (30,000 – 10,000) x 1.7 m2 / 3
• CCI = 11,333 m2 /ul
• So response is adequate. If CCI is below 5000 on 2 consecutive plt transfusion is presumptive evidence of plt refractoriness.
• Patient who are refractory should receive HLA matched or platelet crossmatched platelets
![Page 24: Blood component therapy and transfucion reactions](https://reader031.fdocuments.net/reader031/viewer/2022021922/58738f8b1a28ab272d8b79cf/html5/thumbnails/24.jpg)
Platelets (plt)
• Indications for Platelets
• Count of 10,000 or less in non bleeding patients
• Count of 50,000 or less in acute hemorrhage
• 100,000 or less if bleeding into a critical space such as the lung, eye, or CNS
• Plt dysfxn (Aspirin, cardiopulmonary bypass)
• Contraindications for platelets
• Thrombotic thrombocytopenia purpura (TTP) [↑plt =↑thrombi]
• HIT type II [↑plt =↑thrombi]
• ITP [just doesn’t help]
• Post transfusion purpura.
![Page 25: Blood component therapy and transfucion reactions](https://reader031.fdocuments.net/reader031/viewer/2022021922/58738f8b1a28ab272d8b79cf/html5/thumbnails/25.jpg)
Platelets (plt)
• Q: plt have to be ABO Rh compatible?
• A: general answer is NO*(for adults). Plts express some
ABO antigen but not Rh. ABO incompatible platelets may
get cleared from the recipient's circulation more rapidly,
thus less effective…but you use what you have.
• *may consider Rhogram when RH+ plt is being transfused
to a Rh- reproductive age female (b/c plt preparation may
contain few RBC contaminates). Neonates should also
get type specific plt.
![Page 26: Blood component therapy and transfucion reactions](https://reader031.fdocuments.net/reader031/viewer/2022021922/58738f8b1a28ab272d8b79cf/html5/thumbnails/26.jpg)
![Page 27: Blood component therapy and transfucion reactions](https://reader031.fdocuments.net/reader031/viewer/2022021922/58738f8b1a28ab272d8b79cf/html5/thumbnails/27.jpg)
Fresh Frozen Plasma (FFP)
• Spec: 200-250 ml
• contains all coagulation factors.
• Use/don’t abuse
• Not necessary to restore 100% of patient’s coag factors to
achieve hemostasis. (generally 20-30% should be good).
• Half-life for factor VII is only 4 hrs.
• Plasma should be compatible with the patient’s red blood
cells ( AB blood group is universal FFP donor and O blood
group is universal FFP recipient).
![Page 28: Blood component therapy and transfucion reactions](https://reader031.fdocuments.net/reader031/viewer/2022021922/58738f8b1a28ab272d8b79cf/html5/thumbnails/28.jpg)
Fresh Frozen Plasma (FFP)
• Dosage for Fresh Frozen Plasma
• 10-20mL/kg for initial dosing
• 20mL/kg for patients with liver disease
• These doses should raise factor levels by about 25%
unless the patient is bleeding or in DIC
• Further guidance by clinical response and PT/PTT
measurements.
• Don’t administer FFP with a goal of brining INR to 1. Not
a realistic goal.
![Page 29: Blood component therapy and transfucion reactions](https://reader031.fdocuments.net/reader031/viewer/2022021922/58738f8b1a28ab272d8b79cf/html5/thumbnails/29.jpg)
Fresh Frozen Plasma (FFP)
• Common Indication for FFP
• Multiple coagulation factor deficiencies
• Urgent reversal Vitamin K dependent Factors (II, VII, IX,
X) due to Coumadin and pt is bleeding.
• Trauma (some advocate 1:1 pRBC:FFP ratio).
• Dilution coagulopathy (s/p transfusion of 10+ pRBCs).
• TTP/HUS (supplement ADAMTS13 level)
• Contraindication for FFP:
• Volume expansion
• Heparin reversal
• If specific factor concentrates are available (factor VIII and IX).
![Page 30: Blood component therapy and transfucion reactions](https://reader031.fdocuments.net/reader031/viewer/2022021922/58738f8b1a28ab272d8b79cf/html5/thumbnails/30.jpg)
Cryoprecipitate (Cryo)
• Cryo is prepared by thawing FFP at 1-6oC and refreezing
the precipitate within 1 hr.
• Spec: 15 ml
> 150 mg fibrinogen (usually 250mg)
> 80 IU factor VIII.
80-120 IU of vWF
40-60 IU of factor XIII
• Cryo has only 4 hr shelf life.
• Rich in Factor VIII, but seldom used for hemophilia
because of commercial products
![Page 31: Blood component therapy and transfucion reactions](https://reader031.fdocuments.net/reader031/viewer/2022021922/58738f8b1a28ab272d8b79cf/html5/thumbnails/31.jpg)
Cryoprecipitate (Cryo)
• Indication for Cryo:
• Fibrinogenemia (< 80-100mg/dL) in bleeding patient*
• Disseminated Intravascular Coagulation (DIC)
• Hemophilia A (rich in factor VIII)
• VonWillibrand’s Factor deficiency
• Fibrinogen replacement in massive transfusion.
Unit vs unit, FFP (400mg) actually has more fibrinogen than Cryo (250mg). But main reason to use Cryo is volume.
e.g. to give approx 2500 mg of fibrinogen:
1) 10 units Cryo = 150 ml
2) 6 ¼ units FFP = approx 1.5 liters!
![Page 32: Blood component therapy and transfucion reactions](https://reader031.fdocuments.net/reader031/viewer/2022021922/58738f8b1a28ab272d8b79cf/html5/thumbnails/32.jpg)
Cryoprecipitate (Cryo)
• Dosage for Cryo
• 1 unit of cryo increases the fibrinogen count by about
7mg/dL ( in a 70kg adult)
• Calculate blood volume = Weight in (kg) x 70 mL/kg
• Blood volume (mL) x (1.0 – hematocrit) = plasma volume (mL)
• Mg of fibrinogen required = (desired fibrinogen level in mg/dL – initial fibrinogen level mg/dL) x plasma volume (mL)/100 mL/dL
• Bags of Cryo required = mg of fibrinogen required/250 mg/bag of Cryo
![Page 33: Blood component therapy and transfucion reactions](https://reader031.fdocuments.net/reader031/viewer/2022021922/58738f8b1a28ab272d8b79cf/html5/thumbnails/33.jpg)
Summary of Blood Products
![Page 34: Blood component therapy and transfucion reactions](https://reader031.fdocuments.net/reader031/viewer/2022021922/58738f8b1a28ab272d8b79cf/html5/thumbnails/34.jpg)
Massive Transfusion
• Replacement of one or more blood volumes in less than
24 hours (around 10-12 units) or 5000mL in 70-kg adult
• Associated with dilutional coagulopathy
• Hypothermia
• Hypocalcemia (due to citrate in the blood units)
![Page 35: Blood component therapy and transfucion reactions](https://reader031.fdocuments.net/reader031/viewer/2022021922/58738f8b1a28ab272d8b79cf/html5/thumbnails/35.jpg)
Massive Transfusion
• Administer RBCs to maintain oxygen carrying capacity
when HCT is less 21-24% (or symptomatic) or Loss of
25% or greater of blood volume
• Administer 2-4 units of FFP after administering 4-6 units
of RBCs and continuing blood loss
• Administer 10 bags cryo if fibrinogen is less than 100.
• Administer platelets if platelet count is less than 100,000
and head trauma.
![Page 36: Blood component therapy and transfucion reactions](https://reader031.fdocuments.net/reader031/viewer/2022021922/58738f8b1a28ab272d8b79cf/html5/thumbnails/36.jpg)
Massive Transfusion
1 unit of FFP ≈ 2 units of cryo
1 unit of FFP for every 2-3 units of RBCs (or even 1:1 as
some may advocate)
14 units of cryo raise the fibrinogen by 100mg/dL
![Page 37: Blood component therapy and transfucion reactions](https://reader031.fdocuments.net/reader031/viewer/2022021922/58738f8b1a28ab272d8b79cf/html5/thumbnails/37.jpg)
Transfusion Reactions
![Page 38: Blood component therapy and transfucion reactions](https://reader031.fdocuments.net/reader031/viewer/2022021922/58738f8b1a28ab272d8b79cf/html5/thumbnails/38.jpg)
Transfusion Reactions With Fever
Without Fever
Acute (usually within 24hr).
Acute
Delayed
Delayed
Acute hemolytic
Febrile nonhemolytic
Bacterial contamination (septic)
TRALI
Delayed hemolytic
TA-GVHDz
Urticarial RXN
Anaphylactic
TACO (overload)
(medicated) febrile
Post-transfusion purpura
Iron overload
![Page 39: Blood component therapy and transfucion reactions](https://reader031.fdocuments.net/reader031/viewer/2022021922/58738f8b1a28ab272d8b79cf/html5/thumbnails/39.jpg)
Source: Joe Chaffin, MD
![Page 40: Blood component therapy and transfucion reactions](https://reader031.fdocuments.net/reader031/viewer/2022021922/58738f8b1a28ab272d8b79cf/html5/thumbnails/40.jpg)
Transfusion Reactions
• General rule: assume all reactions are hemolytic, until proven otherwise.
• 1st thing: STOP THE TRANSFUSION!!!!!!!!!
• Amount of incompatible blood administered is the main indicator of patient survival from acute hemolytic transfusion reaction
Workup:
• Clerical check
• Visible hemoglobinemia check (spin post-transfusion sample and look for hemolysis).
• DAT (Coomb’s test)
• Repeat ABO testing
• Others: repeat Ab screen, indirect bili, Haptoglobin, UA(urine hemoglobin)
• Selected types of transfusion reaction will be discussed further.
![Page 41: Blood component therapy and transfucion reactions](https://reader031.fdocuments.net/reader031/viewer/2022021922/58738f8b1a28ab272d8b79cf/html5/thumbnails/41.jpg)
Transfusion Reactions (USNHJ)
![Page 42: Blood component therapy and transfucion reactions](https://reader031.fdocuments.net/reader031/viewer/2022021922/58738f8b1a28ab272d8b79cf/html5/thumbnails/42.jpg)
Transfusion Reactions (NHCP)
• Notify NHCP Laboratory.
• Refer to SOP NO: 6.201/002
• SOP Title: Suspected Transfusion Reaction Work-up
![Page 43: Blood component therapy and transfucion reactions](https://reader031.fdocuments.net/reader031/viewer/2022021922/58738f8b1a28ab272d8b79cf/html5/thumbnails/43.jpg)
Transfusion Reactions
• Acute hemolytic transfusion reaction:
• Maybe fatal, usually ABO related
• Symptoms/findings: fever/chill, back pain, hypotension, DIC,
hemoglobinuria, Schistocytes.
• Ag-Ab complex activates coag factors DIC
bradykinins systemic hypotension
• Treatment: (obviously stop the transfusion 1st).
• Support volume and blood pressure
• Maintain urine output (>100 ml/hr)
• Monitor for DIC.
![Page 44: Blood component therapy and transfucion reactions](https://reader031.fdocuments.net/reader031/viewer/2022021922/58738f8b1a28ab272d8b79cf/html5/thumbnails/44.jpg)
Transfusion Reactions
• Febrile nonhemolytic transfusion reaction:
• Symptoms: +fever/chills, no laboratory findings of
hemolysis.
• Mechanisms:
• Due to release of pyogenic cytokines. (TNF, IL-1beta)
• Prevention: leukoreduction (prestorage)
• Treatment: acetaminophen (premedicate).
![Page 45: Blood component therapy and transfucion reactions](https://reader031.fdocuments.net/reader031/viewer/2022021922/58738f8b1a28ab272d8b79cf/html5/thumbnails/45.jpg)
Transfusion Reactions
• Bacterial Contamination (Septic)
• bacterial contamination is the #1 infectious risk of blood
transfusion
• RBC (cold): gram =, Yersinia enterocolitica, citrobacter, E.
coli, Pseudomonas
• Platelet (room temp): gram + cocci.
• Clinical findings: high fever/ rigor/ N/V.
• Lab: +/- hemoglobinemia/uria, neg DAT, positive gram
stain (in only 50% of cases), Blood culture positive.
• Tx: IV Abx, pressure support.
![Page 46: Blood component therapy and transfucion reactions](https://reader031.fdocuments.net/reader031/viewer/2022021922/58738f8b1a28ab272d8b79cf/html5/thumbnails/46.jpg)
Bacterial contamination of platelet products has been acknowledged
as the most frequent infectious risk from transfusion occurring in
approximately 1 of 2,000 - 3,000 whole-blood derived, random donor
platelets, and apheresis-derived, single donor platelets. -Hillyer, “Bacterial Contamination of Blood Components: Risks, Strategies, and Regulation.”
Hematology 2003
Source: Chaffin, Blood Bank IV, Osler Inst.
![Page 47: Blood component therapy and transfucion reactions](https://reader031.fdocuments.net/reader031/viewer/2022021922/58738f8b1a28ab272d8b79cf/html5/thumbnails/47.jpg)
Transfusion Reactions
• TRALI (transfusion related acute lung injury):
#1 cause of transfusion-related fatality in the U.S. (morality 5 -25%)
• NHLBI definition:
• 1) new acute lung injury < 6hr after completing blood transfusion.
• 2) hypoxia
• 3) bilateral infiltrate on CXR
• 4) no other risk factor for pulmonary edema.
• Most commonly associated with platelets and FFP.
• Not been reported with plasma derivatives (IVIG, Albumin)
• Initially, TRALI is indistinguishable from ARDS. Don’t wait/need for lab results for management of TRALI. (test takes weeks).
• Will know in a few days. (TRALI usually resolves in a few days).
• That being said, TRALI should be a dx of exclusion.
![Page 48: Blood component therapy and transfucion reactions](https://reader031.fdocuments.net/reader031/viewer/2022021922/58738f8b1a28ab272d8b79cf/html5/thumbnails/48.jpg)
Transfusion Reactions
• TRALI (con’t)
• 2 possible mechanisms:
• A) Donor Ab hypothesis: Donor’s anti-HLA or anti-neutrophil Ab attack recipient's WBC. immune complex deposit in pulmonary vasculature.
• B) Non-immune(2-event) hypothesis:
1) preexisting stress that “primes” recipient's
neutrophils.
2) BRMs (lipids) in stored blood product activates
primed neutrophils and deposit in pulmonary
vasculature
Treatment: same as ARDS (Vent, O2, Pressers)
Donor selection: implicated donors are deferred, utilize plasma product form males donors (women have higher incidence of Abs due to pregnancy).
![Page 49: Blood component therapy and transfucion reactions](https://reader031.fdocuments.net/reader031/viewer/2022021922/58738f8b1a28ab272d8b79cf/html5/thumbnails/49.jpg)
Transfusion Reactions
• TACO (transfusion-associated circulatory overload).
• Risk: CHF pts, very young or very old, CRF, chronic
anemia pts.
• TACO vs. TRALI:
• TACO responds to diuretics and usually no fever
• TRALI does not respond to diuretics and is associated
with fever.
• Prevention of TACO:
• Slow infusion rate, consider split units.
![Page 50: Blood component therapy and transfucion reactions](https://reader031.fdocuments.net/reader031/viewer/2022021922/58738f8b1a28ab272d8b79cf/html5/thumbnails/50.jpg)
![Page 51: Blood component therapy and transfucion reactions](https://reader031.fdocuments.net/reader031/viewer/2022021922/58738f8b1a28ab272d8b79cf/html5/thumbnails/51.jpg)
Transfusion Reactions
• Delayed hemolytic transfusion reaction:
• Hemolysis that occurs days~weeks after transfusion, due
to:
• 1) Anamnestic response (previous formed Ab comes
roaring back after re-exposure; Kidd [Jk])
• 2) Primary response (new Ab formed while foreign RBC
are still circulating)
• Findings: +/- fever, mild jaundice, anemia, +“mixed-field”
DAT, previous neg now pos antibody screen.
• Tx: treat as AHTR if symptomatic, otherwise monitor.
![Page 52: Blood component therapy and transfucion reactions](https://reader031.fdocuments.net/reader031/viewer/2022021922/58738f8b1a28ab272d8b79cf/html5/thumbnails/52.jpg)
Transfusion Reactions
• Urticarial transfusion reaction:
• Symptoms: localized hives ONLY, no fever, no perioral swelling.
• Due to hypersensitivity to donor’s plasma proteins (even minute amounts).
• If rash appears rate-dependent, then may be safe to restart transfusion (at a slower rate), once the rash has resolved.
• DDx: harbinger of anaphylactic reaction.
• Tx: Benadryl.
• using washed pRBC or deglyc’ed pRBC can lower incidence of urticarial transfusion reaction.
![Page 53: Blood component therapy and transfucion reactions](https://reader031.fdocuments.net/reader031/viewer/2022021922/58738f8b1a28ab272d8b79cf/html5/thumbnails/53.jpg)
Transfusion Reactions
• Anaphylactic/anaphylactoid reactions:
• Towards the opposite spectrum of the allergy spectrum, compared to urticarial reaction.
• Distinction between anaphylactic vs. anaphylactoid rest of if the reaction is IgE mediated.
• Symptoms: rash, dyspnea, circulatory collapse.
• Examples include:
IgA deficient pt receives a “normal” donor’s blood.
Donor is on a medication for which the recipient is allergic to.
• Tx: Epi, IV steroids, pressors (if severe)
![Page 54: Blood component therapy and transfucion reactions](https://reader031.fdocuments.net/reader031/viewer/2022021922/58738f8b1a28ab272d8b79cf/html5/thumbnails/54.jpg)
Transfusion Reactions
• Post Transfusion Purpura:
• Marked thrombocytopenia approx 1 week s/p transfusion.
• Multiparous female especially at risk.
• Mechanism:
• PLA1 neg patient is exposed to PLA1 pos platelet
• Abs are formed which now destroys both PLA1 pos and to
PLA1 neg platelets*.
• Tx: IVIG.
• *due to passive reabsorption of Ag-Ab complex or autoAb.
![Page 55: Blood component therapy and transfucion reactions](https://reader031.fdocuments.net/reader031/viewer/2022021922/58738f8b1a28ab272d8b79cf/html5/thumbnails/55.jpg)
The End